Stocks and Investing
Stocks and Investing
Wed, February 27, 2013
[ 05:45 AM ] - United States, WOPRAI
[ 04:49 AM ] - United States, Market Wire
[ 04:45 AM ] - United States, Market Wire
[ 04:30 AM ] - United States, Market Wire
[ 04:00 AM ] - United States, Market Wire
[ 03:48 AM ] - United States, WOPRAI
[ 03:48 AM ] - United States, WOPRAI
[ 03:47 AM ] - United States, WOPRAI
[ 03:47 AM ] - United States, WOPRAI
[ 03:46 AM ] - United States, WOPRAI
[ 03:46 AM ] - United States, WOPRAI
[ 03:46 AM ] - United States, WOPRAI
[ 03:45 AM ] - United States, WOPRAI
[ 03:30 AM ] - United States, Market Wire
[ 03:00 AM ] - United States, Market Wire
[ 01:47 AM ] - United States, WOPRAI
[ 01:47 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sumant Kulkarni Upgraded (BIIB) to Strong Buy and Increased Target to $187 on, Feb 27th, 2013
Sumant Kulkarni of Canaccord Genuity, Upgraded "Biogen Inc." (BIIB) to Strong Buy and Increased Target from $163 to $187 on, Feb 27th, 2013.
Sumant has made no other calls on BIIB in the last 4 months.
There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 2 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $166 on, Thursday, January 3rd, 2013
- Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $141 on, Thursday, January 3rd, 2013
These are the ratings of the 2 analyists that currently disagree with Sumant
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $185 on, Friday, February 8th, 2013
- Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, February 6th, 2013
Contributing Sources